Clinical Trial: Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06973499) titled 'Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer' on June 25, 2022.

Brief Summary: This is an exploratory, single-center, being conducted at Beijing Haidian Hospital in order to detect the relationship between microbiome of upper gastrointestinal and pathogenesis of multiple primary lung cancer.

Study Start Date: Jan. 06, 2023

Study Type: OBSERVATIONAL

Condition: Multiple Primary Lung Cancer Microbial Colonization

Intervention: DIAGNOSTIC_TEST: Microbiome Profiling and Symptom Assessment

GERD symptom assessment: Standardized GERD-Q questionnaire to evaluate reflu...